Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin? Stella PapachristouNikolaos Papanas Editorial Open access 14 March 2021 Pages: 965 - 968
Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies Thomas M. CaparrottaJack B. TempletonHelen M. Colhoun Review Open access 26 February 2021 Pages: 969 - 989
Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies Thomas M. CaparrottaAndrew M. GreenhalghHelen M. Colhoun Review Open access 04 March 2021 Pages: 991 - 1028
Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus Qiu WangLirong MaGuang Wang Original Research Open access 24 February 2021 Pages: 1029 - 1039
Ten-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Patients with Type 2 Diabetes Mellitus Suffering from Left Main Coronary Disease: A Meta-Analysis Hong WangHongli WangMohamad A. Ahmed Original Research Open access 27 February 2021 Pages: 1041 - 1054
The Effects of Dietary Nutrition Intake on Glycemic Variability in Type 1 Diabetes Mellitus Adults Liyuan ZhouMingqun DengXinhua Xiao Original Research Open access 27 February 2021 Pages: 1055 - 1071
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis Riccardo C. BonadonnaDidac MauricioPierre Gourdy Original Research Open access 01 March 2021 Pages: 1073 - 1097
Oral Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses Richard E. PratleyMatthew J. CrowleyJohn B. Buse Original Research Open access 04 March 2021 Pages: 1099 - 1116
Fasting Blood Glucose and 2-h Postprandial Blood Glucose Predict Hypertension: A Report from the REACTION Study Yingkui SiAnping WangZhaohui Lyu Original Research Open access 04 March 2021 Pages: 1117 - 1128
A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes Yoshio NagaiKiyoyasu KazumoriYasushi Tanaka Original Research Open access 07 March 2021 Pages: 1129 - 1141
Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey Sandro GentileGiuseppina GuarinoAMD-OSDI Study Group Original Research Open access 09 March 2021 Pages: 1143 - 1157
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis Didac MauricioPierre GourdyDirk Müller-Wieland Original Research Open access 09 March 2021 Pages: 1159 - 1174
Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV Krzysztof StrojekA. Shekhar PandeyIra Gantz Original Research Open access 10 March 2021 Pages: 1175 - 1192
Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study Ebaa Al-OzairiMahir K. JalloMaysoon Loulou Original Research Open access 10 March 2021 Pages: 1193 - 1207
Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset Maximilian GablerNils PickerThomas Wilke Original Research Open access 12 March 2021 Pages: 1209 - 1226